Updated (twice): The FDA has published my comment about Molnupiravir, submitted timely on November 15 .The comment is for the upcoming AMDAC meeting which will discuss Molnupiravir. This is an attachment – Molnupiravir: ineffective, carcinogenic, and a global threat.
My apologies to the FDA for the duplicate submission.